Have any question? Call Us Now?

    Stem Cell Treatment for Stargardt’s Disease in Egypt: genes, drugs and cells compared

    Families in Cairo, Alexandria and across Egypt often hear about stem cells first. This page places cell therapy next to gene and drug research for Stargardt’s, so you can see where each stands.

    Stem cell treatment for Stargardt’s disease in Egypt

    Three research tracks, not one

    Stargardt’s research follows three main paths. Gene approaches try to supply a working copy of the ABCA4 gene, drug approaches try to slow the build-up of toxic waste in the retina, and cell approaches aim to replace the failing support layer.

    Each path suits a different stage of disease. Understanding which one applies to your child or to you prevents hope being placed in the wrong place.

    How the three tracks differ

    A side-by-side view.

    • Gene approachesAim at the cause, and usually need a confirmed genetic result.
    • Drug approachesAim to slow disease, and may suit earlier stages.
    • Cell approachesAim to replace support cells, and are tested mainly in advanced disease.
    • Combination thinkingFuture treatment may use more than one method.
    • Where you fitDepends on your genes, age and retinal condition.

    Where cell therapy stands among them

    Described without exaggeration.

    Earliest stage of testing

    Human studies are small and short.

    Targeted at advanced eyes

    Most volunteers have already lost central vision.

    Safety first

    Early work looks mainly at whether the procedure is tolerated.

    Open question

    Whether cells can protect or restore sight in the long term.

    Using the map to plan

    Practical next steps.

    Get the gene result

    It decides which gene studies are relevant.

    Bring recent OCT scans

    They show how much retina remains.

    Ask about all three tracks

    Not only cells.

    Revisit every year

    The field moves quickly.

    Our Medical Experts – Trusted Specialists

    Eye Stem Cell Center brings together pioneers in stem cell biotechnology and highly experienced ophthalmologists to provide advanced regenerative eye care with compassion and precision.

    Dr. Pallavi

    Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience

    Dr. Pallavi is renowned for her expertise in cataract and corneal surgeries. With thousands of successful procedures, she combines surgical precision with a patient‑first approach.

    Get Consultation

    Dr. Robin

    Consultant Ophthalmologist & Eye Surgeon | MD, DO 16+ Years Experience

    Dr. Robin specializes in advanced cataract surgery, refractive procedures, and keratoconus treatment. His clinical excellence ensures patients receive world‑class eye care.

    Get Consultation

    Dr. Pawan

    Associate Professor | Vitreo-Retina Surgeon 10+ Years Experience

    Dr. Pawan is an expert in retinal disorders, diabetic retinopathy, and advanced retina procedures. His patient‑focused approach ensures precise treatment and long‑term vision care.

    Get Consultation

    Frequently asked questions

    Is a gene therapy for Stargardt’s available now?

    Not as an approved treatment. Gene and drug studies are ongoing.

    Are cells better than drugs?

    There is no proof that either is better, because they are tested at different stages.

    Can we get advice from Egypt?

    Yes. Scans and reports can be sent for review before any other step.

    Our Customer Experiences

    Query form


      Translate »